Publication:
Low oocyte maturity rate and asynchronous follicle development: other unnoticed groups in the Bologna Criteria for poor responders?

Thumbnail Image

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU-Authors

KU Authors

Co-Authors

Ertaş, Sinem

Publication Date

Language

Embargo Status

NO

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Introduction: this study aimed to evaluate the prognosis of patients with low rates of oocyte maturity and compare those who are aforethought poor responders with respect to the Bologna criteria. Methods: all assisted reproductive technology (ART) cycles conducted from 2004 to 2018 in a tertiary center in Istanbul were analyzed retrospectively. Patients were grouped into three accordingly the count of total retrieved oocytes and metaphase-II [(M-II) -mature] oocytes after denudation (group 1: <= 3 oocytes and <= 3 M-II oocytes; group 2: >3 oocytes and <= 3 M-II oocytes; group 3: >3 oocytes and >3 M-II oocytes). A Low oocyte maturity rate was diagnosed when s50% of all harvested oocytes were in the M-II stage before the fertilization procedure. Results: during the study period 14,899 intracytoplasmic sperm injection cycles were evaluated. The study group's mean age was 32.6 +/- 5.3. The mean counts of total and mature oocytes were 9.8 +/- 5.9 and 7.3=4.5, respectively. A mean count of 2.38 embryos was transferred in 10118 cycles. The group 3 patients had a considerably higher live birth ratio compared to the group 1 and 2. Conclusion: we propose oocyte maturity rate and the count of M-I1 oocytes as two diagnostic criteria for the case definition of asynchronous follicle growth. Based on our findings, stimulation cycles ending with low oocyte maturity rate (<= 50%) and <= 3 M-II oocytes would be considered asynchronous follicle development. Patients with low oocyte maturity rate and asynchronous follicle development should be counseled and informed regarding potential poor prognosis of the treatment.

Source

Publisher

Galenos Yayınevi

Subject

General and internal medicine

Citation

Has Part

Source

Istanbul Medical Journal

Book Series Title

Edition

DOI

10.4274/imj.galenos.2022.84748

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

2

Views

8

Downloads

View PlumX Details